CareFusion Mulls Relaunch Of Alaris SE After FDA Lifts Injunction

CareFusion said it is evaluating a timeline for re-introducing its Alaris SE infusion pump after FDA recently informed the firm it has lifted an injunction barring sales of the devices in the U.S